Stonepine Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-517,445
Closed -$3.27M 33
2021
Q2
$3.27M Sell
517,445
-357,735
-41% -$2.31M 1.71% 15
2021
Q1
$5.41M Buy
875,180
+75,180
+9% +$456K 2.92% 13
2020
Q4
$5.53M Sell
800,000
-1,562,240
-66% -$10M 4.23% 7
2020
Q3
$13.3M Sell
2,362,240
-377,401
-14% -$1.8M 13.86% 2
2020
Q2
$14M Buy
2,739,641
+155,855
+6% +$649K 27.06% 1
2020
Q1
$8.89M Sell
2,583,786
-416,214
-14% -$2.43M 9.4% 2
2019
Q4
$25.7M Sell
3,000,000
-825,903
-22% -$2.95M 17.94% 2
2019
Q3
$4.29M Sell
3,825,903
-287,619
-7% -$335K 4.16% 10
2019
Q2
$5.35M Buy
4,113,522
+38,578
+0.9% +$52.9K 3.68% 11
2019
Q1
$5.75M Buy
4,074,944
+2,643
+0.1% +$3.7K 3.31% 13
2018
Q4
$4.89M Buy
4,072,301
+1,747,519
+75% +$3.39M 4.29% 10
2018
Q3
$5.49M Buy
2,324,782
+412,764
+22% +$1.03M 3.21% 11
2018
Q2
$5.22M Buy
1,912,018
+318,899
+20% +$880K 3.17% 12
2018
Q1
$4.37M Sell
1,593,119
-756,881
-32% -$2.19M 2.34% 13
2017
Q4
$7.33M Sell
2,350,000
-1,137,209
-33% -$3.2M 4.39% 10
2017
Q3
$9.83M Sell
3,487,209
-88,980
-2% -$240K 5.8% 9
2017
Q2
$9.15M Buy
3,576,189
+59,700
+2% +$163K 4.94% 8
2017
Q1
$12.9M Buy
3,516,489
+1,223,589
+53% +$5.17M 7.25% 6
2016
Q4
$11.1M Buy
+2,292,900
New +$68.1M 6.6% 7

Other funds holding ISEE

Stonepine Capital Management's ISEE Position: Q3 2021 in Review

Stonepine Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2021, closing a stake of 517,445 shares — an estimated $3.27M sold.

Stonepine Capital Management first reported a position in ISEE in Q4 2016 and held it in 19 quarters. The position peaked at $25.7M in Q4 2019. 149 funds tracked by Wall St. Rank hold ISEE as of Q3 2021.

  • Stonepine Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Stonepine Capital Management sold 517,445 IVERIC bio, Inc. Common Stock shares in Q3 2021, an estimated $3.27M.
  • Stonepine Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2016 and held it in 19 quarters.
  • Stonepine Capital Management's IVERIC bio, Inc. Common Stock position peaked at $25.7M in Q4 2019.
  • 149 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2021.

Based on Stonepine Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.